Onsite Participants. The Act specifies a payment of $75,000 to individuals who participated onsite in a test involving the atmospheric detonation of a nuclear device, and who later developed a specified compensable disease.
A. Exposure. The claimant must have been present “onsite” above or within the official boundaries of the Nevada, Pacific, Trinity, or South Atlantic Test Sites at any time during a period of atmospheric nuclear testing and must have “participated” during that time in the atmospheric detonation of a nuclear device.
B. Disease. After the onsite participation, the claimant developed one of the following specified diseases: leukemia (other than chronic lymphocytic leukemia), lung cancer, multiple myeloma, lymphomas (other than Hodgkin’s disease), and primary cancer of the thyroid, male or female breast, esophagus, stom